Send us a text

There’s no shortage of data in healthcare.

However, when it comes to deeper insights into patients’ futures and provider costs, the industry is sorely lacking.

Is it possible to unlock this data and create both better patient outcomes and more profits for providers?

In this episode of HealthBiz Briefs, guest Brad Bostic, chairman and CEO of hc1, dives into the role of diagnostic testing labs and the ability to turn them into strategic assets by identifying risks before they become dangerous and costly problems.

This episode is brought to you by BetterHelp. Give online therapy a try at https://betterhelp.com/caretalk and get on your way to being your best self.

As a BetterHelp affiliate, we may receive compensation from BetterHelp if you purchase products or services through the links provided.

🎙️⚕️ABOUT CARETALK
CareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.

🎙️⚕️ ABOUT BRAD BOSTIC
For 25 years, Brad Bostic has led and invested in high-growth tech companies. Driven to improve patient care, he founded hc1 to enable precise diagnoses and treatments through optimized lab testing. Under his leadership, hc1 grew from a startup to a global leader, analyzing lab data for over 260 million patients using AI. Recognized for his transformational leadership, Brad has significantly enhanced enterprise value and was named "2020 Dynamic Business Leader of the Year" by the Indiana Chamber of Commerce and a “Top Entrepreneur” by Becker’s Healthcare.

🎙️⚕️ ABOUT HC1
Founded in 2011, hc1 leverages lab data to generate actionable insights that enhance patient care, streamline lab operations, and reduce costs. Today, hc1 processes data for over 90 million patients, managing 30 billion clinical transactions monthly on its secure AWS-powered platform. Their solutions, including hc1 Performance Analytics™ and PrecisionDx Advisor™, enable labs to optimize testing and treatment decisions. With its 2024 acquisition of Accumen, hc1 now offers comprehensive solutions to transform labs into strategic assets for health systems, driving precision diagnostics and improved outcomes.

GET IN TOUCH
Become a CareTalk sponsor
Guest appearance requests
Visit us on the web
Subscribe to the CareTalk Newsletter

Support the show

⚙️CareTalk: Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.